News

IMV Inc. announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio) announced that it has entered into a research collaboration and licensing agreement with the University of North Carolina at Chapel Hill (UNC)…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based…
Read More...

Merck, known as MSD outside the United States and Canada, announced top-line efficacy results from two ongoing pivotal Phase 3 trials (COUGH-1 and COUGH-2) evaluating the efficacy and…
Read More...

High-level results from the final analysis of the Phase III CASPIAN trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of standard-of-care (SoC) chemotherapies…
Read More...

RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical…
Read More...

OSE Immunotherapeutics SA and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor…
Read More...

Regeneron Pharmaceuticals, Inc. announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before…
Read More...

Celltex Therapeutics Corporation, a Houston, Texas-based biotechnology company founded in 2011 and focused on spearheading breakthroughs in regenerative medicine using adult, autologous…
Read More...

Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of…
Read More...

Aurinia Pharmaceuticals Inc. announced that the Company has initiated a Rolling Submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for…
Read More...

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug…
Read More...

AcelRx Pharmaceuticals announced the execution of a definitive merger agreement to acquire Tetraphase Pharmaceuticals, Inc. (Tetraphase) in a stock for stock deal at an exchange ratio…
Read More...

Regeneron Pharmaceuticals and Sanofi announced they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection. Kevzara is a…
Read More...

XORTX Therapeutics Inc. a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late stage clinical programs, announces that it…
Read More...

BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft.,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced an update from the Phase III JAVELIN Head and Neck 100 study…
Read More...

Thermo Fisher Scientific announced it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion…
Read More...

Eurofins announces that two of its clinical diagnostic testing laboratories in the United States now offer testing for evaluation of COVID-19. On 13 March 2020, Viracor Eurofins, one of…
Read More...